CP (Cerebral Palsy)NCT06719271
Study Aims to Compare the Effect of Robotic-assisted Gait Training and Conventional Treadmill Training on Postural Stability in Ambulatory Children With Cerebral Palsy.
A study testing Participants this group will receive gait training in robotic assisted gait training (RAGT) three times per week for eight weeks and Body Weight Supported Treadmill Training in people with CP (Cerebral Palsy) and Robotic Exoskeleton, run by King Saud University at 1 site in Saudi Arabia.
Trial summary
The aim of this study is to explore the impact of gait training with a robotic device versus treadmill training on enhancing postural stability and walking capabilities in children with cerebral palsy (CP). Read more about this study
- Who is it for?
- Ages 5 to 14 years
- Conditions the study is for
- CP (Cerebral Palsy), Robotic Exoskeleton, Treadmill Locomotor-based Training
- What is being tested?
- Participants this group will receive gait training in robotic assisted gait training (RAGT) three times per week for eight weeks and Body Weight Supported Treadmill Training
- Type of treatment
- Medical device
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 36 participants
- Where
- 1 siteSaudi Arabia
- Study dates
- 25 Sep 2021to 21 Oct 2022
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 5 to 14 years
- All sexes
- No healthy volunteers
- Child
Who may be able to join
- Spastic CP diagnosed from a pediatrician's (Neurology clinic) to have Diaplegia, Diaparesis, Hemiplegia, Hemiparesis, or Quadriparesis.
- Both gender with their age ranged from 5-14 years.
- Independently able to stand and walk or walk with assistance.
- GMFCS Level I and II, with walking limitations, but able to ambulate without the gait device for most distances and with GMFCS Level III, who have a greater degree of walking limitation and able to use wheelchairs or walkers for short to long distances.
- Ability to follow instructions.
- Ability to accurately signal pain and discomfort using verbal or non-verbal signals.
- Ability to be participated in > 45 minutes of active Physical Therapy treatment.
- Hip's and knee's passive range of motion (ROM) within the minimum range requirement for Lokomat (≤10° for hip and knee flexion contracture).
Who cannot join
- Botox injection in lower limb during the last 6 months.
- Surgical intervention in lower limb within a 1-year period prior to the examination date (including tendon release, muscle lengthening and bone surgery).
- Active drug for resisting epilepsy.
- Anatomical leg length differences larger than 2 cm (due to the limitations of Lokomat system).
- Bone-articular instability (joint dislocation).
- Fixed joint contractures; bone and joint deformities of lower extremities.
Show all 13Show fewer
- Baclofen therapy by using an implanted infusion pump.
- Inhibiting casts for lower limb during 6 months prior to the program.
- Significant visual and hearing loss.
- Skin inflammation and open skin lesions around the lower limb or trunk.
- Any significant impairments in endurance due to limitation in cardiovascular system based on the patient's history.
- Cognition (higher mental functions) disorders resulted in lack of patient cooperation.
- Lack of consent from the parent or guardian.
Trial locations and contacts
1 site in 1 country.
Saudi Arabia1 site
Rehabilitation Department, Physiotherapy Outpatient Clinic 750 at King Abdullah Specialized Children Hospital, Ministry of National Guard Health Affair, Riyadh, Saudi Arabia.
Riyadh
About this study
Official title: Postural Stability of Ambulatory Children With Cerebral Palsy After Robotic Assisted Gait Training Versus Body-Weight Supported Treadmill Training Objectives to Compare the Effect of Robotic-assisted Gait Training and Body-weight Supported Treadmill Training on Postural Stability in Ambulatory Children With Cerebral Palsy. Methods: A Randomized Control Study Involved Ambulatory Children With Cerebral Palsy With GMFCS Levels I, II and III. They Were Randomly Allocated to One of Two Locomotor Treadmill Training Groups. Postural Stability Outcomes Will Assessed Before and After the Intervention
The aim of this study is to explore the impact of gait training with a robotic device versus treadmill training on enhancing postural stability and walking capabilities in children with cerebral palsy (CP). The main questions to answer are children with CP who receive Robotic gait training will improve more in their postural stability compared with children with CP who received gait training on Treadmill? Are children with CP who receive Robotic gait training will improve more in their gross motor functions compared with children with CP who received gait training on Treadmill Are children with CP who receive Robotic gait training will improve more in their walking distance compared with children with CP who received gait training on Treadmill? Researchers will compare Group A to Group B to see if Robotic gait training has more effect on their outcomes than treadmill.
Participants will be randomly allocated to one of two group and will receive gait training for 3 times per week for eight weeks. Outcome measures will be assessed in the base line before starting intervention and after completing intervention.
Read more
Study Design A randomized control trial (RCT) Participants and Recruitment The trial will be conducted in Pediatric Out-Patient Rehabilitation Services (Clinic 750) at king Abdullah Specialized Children Hospital (KASCH), National Guard Hospital (NGH) in Riyadh, Saudi Arabia. The study populations are ambulatory children who have been diagnosed to have Spastic CP and who are referred and treated in rehabilitation department at KASCH in NGH in Riyadh. Recruitment will be through their medical record number. Inclusion Criteria are Spastic CP diagnosed from a pediatrician's (Neurology clinic) to have Diplegia, Hemiplegia, or Quadriparesis, Both gender with their age ranged from 5-14 years, independently able to stand and walk or walk with assistance, GMFCS Level I and II, with walking limitations, but able to ambulate without the gait device for most distances and with GMFCS Level III, who have a greater degree of walking limitation and able to use wheelchairs or walkers for short to long distances, Ability to follow instructions, Ability to accurately signal pain and discomfort using verbal or non-verbal signals, Ability to be participated in > 45 minutes of active Physical Therapy treatment, Hip's and knee's passive range of motion (ROM) within the minimum range requirement for robotic device (≤10° for hip and knee flexion contracture).
Exclusion Criteria are Botox injection in lower limb during the last 6 months, Surgical intervention in lower limb within a 1-year period prior to the examination date (including tendon release, muscle lengthening and bone surgery), Active drug for resisting epilepsy, Anatomical leg length differences larger than 2 cm (due to the limitations of robotic device), Bone-articular instability (joint dislocation), Fixed joint contractures; bone and joint deformities of lower extremities, Baclofen therapy by using an implanted infusion pump, Inhibiting casts for lower limb during 6 months prior to the program, Significant visual and hearing loss, Skin inflammation and open skin lesions around the lower limb or trunk, Any significant impairments in endurance due to limitation in cardiovascular system based on the patient's history, Cognition (higher mental functions) disorders resulted in lack of patient cooperation, Lack of consent from the parent or guardian.
Procedure We will send the invitation letter to the parents of participants. If interested, we will provide their parents with the informed consent (written). We will obtain the Assent from children who are unable to provide independent consent. Then, the participants will complete a basic screening session. If the participant met the eligibility criteria of the screening, he/ she will have a robotic device fitting assessment session to confirm there are no concerns with the participation in the study and to use the robotic device. If the participant met these the fitting criteria, the therapist would review the findings and will confirm (with the family) whether the child is eligible for the study based on their findings. The participants will be divided randomly to enter on of the two treatment groups (robotic or treadmill). Each participant will have a baseline assessment during the first two weeks prior to the beginning of the treatment, treatment program for eight weeks, and post treatment assessment at the last two weeks after completing the program. The duration of the whole program is twelve weeks. All participants will be assessed for their balance and walking parameters.
Read the detailed description
Statement of problem:
Limitations in the literatures addressed the effect of robotic gait training on postural stability in CP children. Their limitation where varying levels of evidence, small sample size, different pediatric age groups with different functional levels, variation in setting program's frequency and duration of training and using a variety of assessment tools in assessing postural stability (Sarhan et al., 2014, Druzbicki et al., 2010, Druzbicki et al., 2013, Wallard et al., 2017). Lack of standardization in reporting of all aspects of the evaluation protocol for their assessment tools that used to measure postural stability such as; evaluation time, number of trials, arms and legs position at the time of assessment. This will lead to difficulty in replicating the study (Sarhan et al., 2014, Druzbicki et al., 2010, Druzbicki et al., 2013). The study compared between the effects of RAGT and BWSTT on postural stability did not address all aspects of static and dynamic postural stability. In addition, they did not report their standardization in their evaluation protocol (Sarhan et al., 2014). There was no study used CDP as a reliable, objective assessment tool with standardized protocols in assessing static and dynamic postural stability for CP children who are treated with RAGT compared to CP children who are treated with BWSTT. Since this assessment instrument can collaborate with the better understanding of all aspects concerning postural stability of children with CP, this study will fill the gaps in literature to guide future research that improves the postural control of children with CP.
Objectives of the study:
The primary objective of this study is to evaluate the comparative impact of RAGT and BWSTT for ambulatory children with CP on Static and Dynamic postural stability. The secondary objective is to evaluate the comparative impact of RAGT and BWSTT on Child's gross motor functions. The third objective is to evaluate the comparative impact of RAGT and BWSTT on Child's walking distance (endurance).
Hypothesis: Children with CP how are receiving the robotic gait training will not improve more on their postural stability compared with those receiving the BWSTT program.
Significance of the Study:
Reaching to the highest functional level, which is ambulation, is the main goal of children (and their care giver) with CP. Achieving this goal is vitally depending on improving their postural stability. RAGT holds promise for CP children in improving their postural stability that help in improving their ambulation functions. Both locomotor devices (treadmill and lokomat) provided walking training aiming to improve postural stability in CP patients. Robotic training device is expensive and not easy to be available in all clinics. It requires more time for preparing, adjusting, treating and removing the patient from the device, while the treadmill is accessible and available in most of the clinics, at also easy to administered and it require less time and effort from the therapist comparing to the robotic device. Measuring the comparative effects of both devices on postural stability will help us in rehabilitation clinical setting. If the study results show similar effects of both devices on postural stability, we will eliminate the effort and cost of ordering the expensive device (lokomat) and we will keep the cheaper device in our clinic (Treadmill). We can recommend robotic device to be used in other intensive rehabilitation setting as walking training aiming to improve gait related parameters. However, if the study results showed that; lokomat is superior to treadmill in improving postural stability; we will consider this in our future decision-making regarding requesting this expensive device.
Study Design:
A randomized control trial (RCT)
Participants and Recruitment:
The trial will be conducted in Pediatric Out-Patient Rehabilitation Services (Clinic 750) at king Abdullah Specialized Children Hospital (KASCH), National Guard Hospital (NGH) in Riyadh, Saudi Arabia. The study populations are ambulatory children who have been diagnosed to have Spastic CP and who are referred and treated in rehabilitation department at KASCH in NGH in Riyadh. Recruitment will be through their medical record number.
Inclusion Criteria:
- Spastic CP diagnosed from a pediatrician's (Neurology clinic) to have Diaplegia, Diaparesis, Hemiplegia, Hemiparesis, or Quadriparesis.
- Both gender with their age ranged from 5-14 years.
- Independently able to stand and walk or walk with assistance.
- GMFCS Level I and II, with walking limitations, but able to ambulate without the gait device for most distances and with GMFCS Level III, who have a greater degree of walking limitation and able to use wheelchairs or walkers for short to long distances.
- Ability to follow instructions.
- Ability to accurately signal pain and discomfort using verbal or non-verbal signals.
- Ability to be participated in > 45 minutes of active Physical Therapy treatment.
- Hip's and knee's passive range of motion (ROM) within the minimum range requirement for Lokomat (≤10° for hip and knee flexion contracture).
Exclusion Criteria:
- Botox injection in lower limb during the last 6 months.
- Surgical intervention in lower limb within a 1-year period prior to the examination date (including tendon release, muscle lengthening and bone surgery).
- Active drug for resisting epilepsy.
- Anatomical leg length differences larger than 2 cm (due to the limitations of Lokomat system).
- Bone-articular instability (joint dislocation).
- Fixed joint contractures; bone and joint deformities of lower extremities.
- Baclofen therapy by using an implanted infusion pump.
- Inhibiting casts for lower limb during 6 months prior to the program.
- Significant visual and hearing loss.
- Skin inflammation and open skin lesions around the lower limb or trunk.
- Any significant impairments in endurance due to limitation in cardiovascular system based on the patient's history.
- Cognition (higher mental functions) disorders resulted in lack of patient cooperation.
- Lack of consent from the parent or guardian.
Sample size:
We will estimate the sample size based on the primary research question. The starting point for calculation of our sample size consideration is a one-group Locomotor study and using postural stability as the primary outcome. We will make the calculation by using the score of The Bruininks- Oseretsky Test of Motor Proficiency Subset 2 for balance baseline mean and standard deviation for one groups based on the study of Sarhan et al., (2014). Assuming the total mean difference in balance test of 1.8 and a pooled standard deviation of 1.7 units (Sarhan et al., 2014), the study will require a sample size of 15 participants for each group (i.e. a total sample size of 30, assuming equal group sizes), The desired power of the study will set at 80% and 5% significance level. We will increase the sample requirement to 36 to account for a potential drop out/ protocol deviation rate of 20%. The total sample size is 36 participants.
Ethical Consideration and Consent:
The current study will be approved by the Institutional Review Board (IRB) at King Saud University (KSU), Institutional Review Board (IRB) approval from king Abdullah International Medical Research Center (KAIMRC) in ministry of National Guard Health Affair (MNGHA) in Riyadh. Consent form will be completed by the parents and will be kept enclosed to ensure anonymity and Assent will be completed by children. Therapist is certified to use robotic training device (by having Lokomat user qualification Certificate in completion the training course on robotic rehabilitation therapy with the Lokomat).
Procedure:
We will send the invitation letter to the parents of participants. If interested, we will provide their parents with the informed consent (written). We will obtain the Assent from children who are unable to provide independent consent. Then, the participants will complete a basic screening session. If the participant met the eligibility criteria of the screening, he/ she will have a Lokomat fitting assessment session to confirm there are no concerns with the participation in the study and to use the Lokomat. If the participant met these the fitting criteria, the therapist will review the findings and will confirm (with the family) whether the child is eligible for the study based on their findings. The participants will be divided randomly to enter on of the two treatment groups (robotic or treadmill). Each participant will have a baseline assessment during the first two weeks prior to the beginning of the treatment, treatment program for eight weeks (Lunenburger et al., 2004), and post treatment assessment at the last two weeks after completing the program. The duration of the whole program is twelve weeks. All participants will be assessed for their balance and walking parameters.
Randomization:
Children who assigned a study ID number will attend their baseline assessment. Then, the child will be allocated to start at one of the two groups via a random assignment process by using a computer-generated random number system. The scheme of assignment will be prepared at the beginning of the study using a stratified randomization process (by using age and GMFCS level). At the end of the trial, this system will ensure that the number, age and GMFCS balance of participants who start in the robotic training group and treadmill training groups will be equal. A non-study research assistant (RA) will manage the randomization process through the entire study to allow blinding of the study investigators to the scheme, thus will eliminate the allocation bias.
Interventions:
Thirty sex participants will be divided randomly into two groups. The first group consists of 18 participants. They will receive robotic assisted gait training (RAGT) three times a week for four weeks for 45 minutes duration of session. The second group consists of 18 participants. They will receive body weight supported treadmill training (BWSTT) three times a week for four weeks for 45 minutes duration of session (Sarhan et al., 2014). Participants in both groups will receive a structural home-based individual physical therapy exercises program designed by physiotherapist. This program will mainly focus on stretching exercises, strengthening exercises and aerobic training for the main major muscles of upper and lower extremities (Fauzi et al., 2019). Exercises log will be provided to the participants. The duration of participation for each participant is approximately three months (twelve weeks) as folow; two weeks for baseline assessment, eight weeks for intervention period, and two weeks for post intervention assessment (Lunenburger et al., 2004). The follow-up for each participant during the study is three times per week (Sarhan et al., 2014).
Outcome Measures:
For the outcome measures, the evaluations will be performed twice; at the baseline (prior to the beginning of the treatment) and after finishing the treatment. The outcome measures will be assessed at single points in time to give the strength of objectivity of those outcome measures. The same examiner who will be blinded to the aims of the study and to which group the participant is allocated will perform all evaluation procedures.
The Primary Outcome Measure: Postural stability. The secondary Outcome Measure: gross motor functions. The third Outcome Measure: walking distance.
Statistical Analysis:
All statistical analyses will be performed with IBM SPSS Statistics (version 25) and datasets of all study participants will be analyzed on an intention-to-treat basis. Summary statistics (frequency, mean, standard deviation,) will be generated for all of the main demographic variables; gender, age, BMI, severity of CP according to GMFCS level, and treatment type. t- tests will be performed to determine statistically significant differences between the groups at baseline, statistically significant differences from pre- to post-training for each training group, and statistically significant differences between the training conditions on the outcomes: balance parameters, gross motor functions and Walking distance. Results will be presented as means ± standard deviation (SD) and the differences will be considered significant by keeping the Ninety-five percent confidence interval with a two-tailed level of significance set at p < 0.05 (Sarhan et al., 2014).
- Conditions
- CP (Cerebral Palsy), Robotic Exoskeleton, Treadmill Locomotor-based Training, Postural Stability
- Being tested
- Participants this group will receive gait training in robotic assisted gait training (RAGT) three times per week for eight weeks, Body Weight Supported Treadmill Training
- Keywords
- Robotic Assited Gait Training, postural stability, CP
- Medical subject headings
- Cerebral Palsy
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Participants this group will receive gait training in robotic assisted gait training (RAGT) three times per week for eight weeksDevice
Robotic Assited Gait Training is a device used to train children with CP how to walk in effective manner by connecting their body to the harness, robotic devices that attached to the electronic treadmill
Body Weight Supported Treadmill TrainingDevice
Participants in this group will receive gait training on conventional treadmill three times per week for eight weeks
| Study group | Role | What they receive |
|---|---|---|
| Robotic assisted gait training: participants in this group with receive gait training on the Lokomat | Active comparator | Not described Receives: Device: Participants this group will receive gait training in robotic assisted gait training (RAGT) three times per week for eight weeks |
| Body Weight Supported Treadmill Training: participants in this group receive training on Treadmill | Active comparator | Not described Receives: Device: Body Weight Supported Treadmill Training |
What is being measured
The primary outcome is the main question the study is designed to answer.
Postural Stability using Computerized Dynamic Posturography (CDP)
Measured: Outcome measure performed at baseline (within 1-2 weeks before starting the intervention) and after ending the intervention (within 1-2 weeks after completing the intervention)
Secondary outcomes (1)
Change in gross motor functions measured by GMFM-88
Measured: Outcome measure performed at baseline (within 1-2 weeks before starting the intervention) and after ending the intervention (within 1-2 weeks after completing the intervention)
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted5 Dec 2024
- Study start25 Sep 2021
- Primary completion2 Aug 2022
- Study completion21 Oct 2022
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Publications (1)Papers the sponsor has linked to this study.
- Other trials for CP (Cerebral Palsy)Studies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Single blind
- Who is masked
- Outcomes assessor
- Enrolment
- 36 participants (actual)
Sponsor and investigators
- Lead sponsor
- King Saud University
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Mozainah Yahya Aljoush, King Abdullah International Medical Research Center
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT06719271
- Sponsor's protocol ID
- KAIMRC study number RC19/363/R
- Status last verified
- Dec 2024
- First submitted
- 20 Nov 2024
- Last updated
- 5 Dec 2024
- Results posted
- No
- Data monitoring committee
- Yes
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- Undecided
Publications
Aljosh M, Algabbani MF, Fagehi JM, Bawazeer M, Almohiza MA, Albishi AM, Alhusaini AA. Robotic versus treadmill training: Postural stability in ambulatory CP: RCT study. Pediatr Int. 2025 Jan-Dec;67(1):e70214. doi: 10.1111/ped.70214.
PubMed 41045011
Study at a glance
From the registry record, last updated by the sponsor on 5 Dec 2024. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Postural Stability of Ambulatory Children With Cerebral Palsy After Robotic Assisted Gait Training Versus Body-Weight Supported Treadmill Training Objectives to Compare the Effect of Robotic-assisted Gait Training and Body-weight Supported Treadmill Training on Postural Stability in Ambulatory Children With Cerebral Palsy. Methods: A Randomized Control Study Involved Ambulatory Children With Cerebral Palsy With GMFCS Levels I, II and III. They Were Randomly Allocated to One of Two Locomotor Treadmill Training Groups. Postural Stability Outcomes Will Assessed Before and After the Intervention
- ClinicalTrials.gov ID
- NCT06719271
- Acronym / sponsor ID
- KAIMRC study number RC19/363/R
- Conditions
- CP (Cerebral Palsy), Robotic Exoskeleton, Treadmill Locomotor-based Training, Postural Stability
- Keywords
- Robotic Assited Gait Training, postural stability, CP
- Study type
- Interventional
- Recruitment status
- Completed
- Enrolment
- 36 participants (actual)
- Lead sponsor
- King Saud UniversityUniversity, hospital or other
- Study start
- 25 Sep 2021 (actual)
- Primary completion
- 2 Aug 2022 (actual)
- Study completion
- 21 Oct 2022 (actual)
- First posted
- 5 Dec 2024 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
The aim of this study is to explore the impact of gait training with a robotic device versus treadmill training on enhancing postural stability and walking capabilities in children with cerebral palsy (CP). The main questions to answer are children with CP who receive Robotic gait training will improve more in their postural stability compared with children with CP who received gait training on Treadmill? Are children with CP who receive Robotic gait training will improve more in their gross motor functions compared with children with CP who received gait training on Treadmill Are children with CP who receive Robotic gait training will improve more in their walking distance compared with children with CP who received gait training on Treadmill? Researchers will compare Group A to Group B to see if Robotic gait training has more effect on their outcomes than treadmill.
Participants will be randomly allocated to one of two group and will receive gait training for 3 times per week for eight weeks. Outcome measures will be assessed in the base line before starting intervention and after completing intervention.
Study Design A randomized control trial (RCT) Participants and Recruitment The trial will be conducted in Pediatric Out-Patient Rehabilitation Services (Clinic 750) at king Abdullah Specialized Children Hospital (KASCH), National Guard Hospital (NGH) in Riyadh, Saudi Arabia. The study populations are ambulatory children who have been diagnosed to have Spastic CP and who are referred and treated in rehabilitation department at KASCH in NGH in Riyadh. Recruitment will be through their medical record number. Inclusion Criteria are Spastic CP diagnosed from a pediatrician's (Neurology clinic) to have Diplegia, Hemiplegia, or Quadriparesis, Both gender with their age ranged from 5-14 years, independently able to stand and walk or walk with assistance, GMFCS Level I and II, with walking limitations, but able to ambulate without the gait device for most distances and with GMFCS Level III, who have a greater degree of walking limitation and able to use wheelchairs or walkers for short to long distances, Ability to follow instructions, Ability to accurately signal pain and discomfort using verbal or non-verbal signals, Ability to be participated in > 45 minutes of active Physical Therapy treatment, Hip's and knee's passive range of motion (ROM) within the minimum range requirement for robotic device (≤10° for hip and knee flexion contracture).
Exclusion Criteria are Botox injection in lower limb during the last 6 months, Surgical intervention in lower limb within a 1-year period prior to the examination date (including tendon release, muscle lengthening and bone surgery), Active drug for resisting epilepsy, Anatomical leg length differences larger than 2 cm (due to the limitations of robotic device), Bone-articular instability (joint dislocation), Fixed joint contractures; bone and joint deformities of lower extremities, Baclofen therapy by using an implanted infusion pump, Inhibiting casts for lower limb during 6 months prior to the program, Significant visual and hearing loss, Skin inflammation and open skin lesions around the lower limb or trunk, Any significant impairments in endurance due to limitation in cardiovascular system based on the patient's history, Cognition (higher mental functions) disorders resulted in lack of patient cooperation, Lack of consent from the parent or guardian.
Procedure We will send the invitation letter to the parents of participants. If interested, we will provide their parents with the informed consent (written). We will obtain the Assent from children who are unable to provide independent consent. Then, the participants will complete a basic screening session. If the participant met the eligibility criteria of the screening, he/ she will have a robotic device fitting assessment session to confirm there are no concerns with the participation in the study and to use the robotic device. If the participant met these the fitting criteria, the therapist would review the findings and will confirm (with the family) whether the child is eligible for the study based on their findings. The participants will be divided randomly to enter on of the two treatment groups (robotic or treadmill). Each participant will have a baseline assessment during the first two weeks prior to the beginning of the treatment, treatment program for eight weeks, and post treatment assessment at the last two weeks after completing the program. The duration of the whole program is twelve weeks. All participants will be assessed for their balance and walking parameters.
Detailed description
Statement of problem:
Limitations in the literatures addressed the effect of robotic gait training on postural stability in CP children. Their limitation where varying levels of evidence, small sample size, different pediatric age groups with different functional levels, variation in setting program's frequency and duration of training and using a variety of assessment tools in assessing postural stability (Sarhan et al., 2014, Druzbicki et al., 2010, Druzbicki et al., 2013, Wallard et al., 2017). Lack of standardization in reporting of all aspects of the evaluation protocol for their assessment tools that used to measure postural stability such as; evaluation time, number of trials, arms and legs position at the time of assessment. This will lead to difficulty in replicating the study (Sarhan et al., 2014, Druzbicki et al., 2010, Druzbicki et al., 2013). The study compared between the effects of RAGT and BWSTT on postural stability did not address all aspects of static and dynamic postural stability. In addition, they did not report their standardization in their evaluation protocol (Sarhan et al., 2014). There was no study used CDP as a reliable, objective assessment tool with standardized protocols in assessing static and dynamic postural stability for CP children who are treated with RAGT compared to CP children who are treated with BWSTT. Since this assessment instrument can collaborate with the better understanding of all aspects concerning postural stability of children with CP, this study will fill the gaps in literature to guide future research that improves the postural control of children with CP.
Objectives of the study:
The primary objective of this study is to evaluate the comparative impact of RAGT and BWSTT for ambulatory children with CP on Static and Dynamic postural stability. The secondary objective is to evaluate the comparative impact of RAGT and BWSTT on Child's gross motor functions. The third objective is to evaluate the comparative impact of RAGT and BWSTT on Child's walking distance (endurance).
Hypothesis: Children with CP how are receiving the robotic gait training will not improve more on their postural stability compared with those receiving the BWSTT program.
Significance of the Study:
Reaching to the highest functional level, which is ambulation, is the main goal of children (and their care giver) with CP. Achieving this goal is vitally depending on improving their postural stability. RAGT holds promise for CP children in improving their postural stability that help in improving their ambulation functions. Both locomotor devices (treadmill and lokomat) provided walking training aiming to improve postural stability in CP patients. Robotic training device is expensive and not easy to be available in all clinics. It requires more time for preparing, adjusting, treating and removing the patient from the device, while the treadmill is accessible and available in most of the clinics, at also easy to administered and it require less time and effort from the therapist comparing to the robotic device. Measuring the comparative effects of both devices on postural stability will help us in rehabilitation clinical setting. If the study results show similar effects of both devices on postural stability, we will eliminate the effort and cost of ordering the expensive device (lokomat) and we will keep the cheaper device in our clinic (Treadmill). We can recommend robotic device to be used in other intensive rehabilitation setting as walking training aiming to improve gait related parameters. However, if the study results showed that; lokomat is superior to treadmill in improving postural stability; we will consider this in our future decision-making regarding requesting this expensive device.
Study Design:
A randomized control trial (RCT)
Participants and Recruitment:
The trial will be conducted in Pediatric Out-Patient Rehabilitation Services (Clinic 750) at king Abdullah Specialized Children Hospital (KASCH), National Guard Hospital (NGH) in Riyadh, Saudi Arabia. The study populations are ambulatory children who have been diagnosed to have Spastic CP and who are referred and treated in rehabilitation department at KASCH in NGH in Riyadh. Recruitment will be through their medical record number.
Inclusion Criteria:
- Spastic CP diagnosed from a pediatrician's (Neurology clinic) to have Diaplegia, Diaparesis, Hemiplegia, Hemiparesis, or Quadriparesis.
- Both gender with their age ranged from 5-14 years.
- Independently able to stand and walk or walk with assistance.
- GMFCS Level I and II, with walking limitations, but able to ambulate without the gait device for most distances and with GMFCS Level III, who have a greater degree of walking limitation and able to use wheelchairs or walkers for short to long distances.
- Ability to follow instructions.
- Ability to accurately signal pain and discomfort using verbal or non-verbal signals.
- Ability to be participated in > 45 minutes of active Physical Therapy treatment.
- Hip's and knee's passive range of motion (ROM) within the minimum range requirement for Lokomat (≤10° for hip and knee flexion contracture).
Exclusion Criteria:
- Botox injection in lower limb during the last 6 months.
- Surgical intervention in lower limb within a 1-year period prior to the examination date (including tendon release, muscle lengthening and bone surgery).
- Active drug for resisting epilepsy.
- Anatomical leg length differences larger than 2 cm (due to the limitations of Lokomat system).
- Bone-articular instability (joint dislocation).
- Fixed joint contractures; bone and joint deformities of lower extremities.
- Baclofen therapy by using an implanted infusion pump.
- Inhibiting casts for lower limb during 6 months prior to the program.
- Significant visual and hearing loss.
- Skin inflammation and open skin lesions around the lower limb or trunk.
- Any significant impairments in endurance due to limitation in cardiovascular system based on the patient's history.
- Cognition (higher mental functions) disorders resulted in lack of patient cooperation.
- Lack of consent from the parent or guardian.
Sample size:
We will estimate the sample size based on the primary research question. The starting point for calculation of our sample size consideration is a one-group Locomotor study and using postural stability as the primary outcome. We will make the calculation by using the score of The Bruininks- Oseretsky Test of Motor Proficiency Subset 2 for balance baseline mean and standard deviation for one groups based on the study of Sarhan et al., (2014). Assuming the total mean difference in balance test of 1.8 and a pooled standard deviation of 1.7 units (Sarhan et al., 2014), the study will require a sample size of 15 participants for each group (i.e. a total sample size of 30, assuming equal group sizes), The desired power of the study will set at 80% and 5% significance level. We will increase the sample requirement to 36 to account for a potential drop out/ protocol deviation rate of 20%. The total sample size is 36 participants.
Ethical Consideration and Consent:
The current study will be approved by the Institutional Review Board (IRB) at King Saud University (KSU), Institutional Review Board (IRB) approval from king Abdullah International Medical Research Center (KAIMRC) in ministry of National Guard Health Affair (MNGHA) in Riyadh. Consent form will be completed by the parents and will be kept enclosed to ensure anonymity and Assent will be completed by children. Therapist is certified to use robotic training device (by having Lokomat user qualification Certificate in completion the training course on robotic rehabilitation therapy with the Lokomat).
Procedure:
We will send the invitation letter to the parents of participants. If interested, we will provide their parents with the informed consent (written). We will obtain the Assent from children who are unable to provide independent consent. Then, the participants will complete a basic screening session. If the participant met the eligibility criteria of the screening, he/ she will have a Lokomat fitting assessment session to confirm there are no concerns with the participation in the study and to use the Lokomat. If the participant met these the fitting criteria, the therapist will review the findings and will confirm (with the family) whether the child is eligible for the study based on their findings. The participants will be divided randomly to enter on of the two treatment groups (robotic or treadmill). Each participant will have a baseline assessment during the first two weeks prior to the beginning of the treatment, treatment program for eight weeks (Lunenburger et al., 2004), and post treatment assessment at the last two weeks after completing the program. The duration of the whole program is twelve weeks. All participants will be assessed for their balance and walking parameters.
Randomization:
Children who assigned a study ID number will attend their baseline assessment. Then, the child will be allocated to start at one of the two groups via a random assignment process by using a computer-generated random number system. The scheme of assignment will be prepared at the beginning of the study using a stratified randomization process (by using age and GMFCS level). At the end of the trial, this system will ensure that the number, age and GMFCS balance of participants who start in the robotic training group and treadmill training groups will be equal. A non-study research assistant (RA) will manage the randomization process through the entire study to allow blinding of the study investigators to the scheme, thus will eliminate the allocation bias.
Interventions:
Thirty sex participants will be divided randomly into two groups. The first group consists of 18 participants. They will receive robotic assisted gait training (RAGT) three times a week for four weeks for 45 minutes duration of session. The second group consists of 18 participants. They will receive body weight supported treadmill training (BWSTT) three times a week for four weeks for 45 minutes duration of session (Sarhan et al., 2014). Participants in both groups will receive a structural home-based individual physical therapy exercises program designed by physiotherapist. This program will mainly focus on stretching exercises, strengthening exercises and aerobic training for the main major muscles of upper and lower extremities (Fauzi et al., 2019). Exercises log will be provided to the participants. The duration of participation for each participant is approximately three months (twelve weeks) as folow; two weeks for baseline assessment, eight weeks for intervention period, and two weeks for post intervention assessment (Lunenburger et al., 2004). The follow-up for each participant during the study is three times per week (Sarhan et al., 2014).
Outcome Measures:
For the outcome measures, the evaluations will be performed twice; at the baseline (prior to the beginning of the treatment) and after finishing the treatment. The outcome measures will be assessed at single points in time to give the strength of objectivity of those outcome measures. The same examiner who will be blinded to the aims of the study and to which group the participant is allocated will perform all evaluation procedures.
The Primary Outcome Measure: Postural stability. The secondary Outcome Measure: gross motor functions. The third Outcome Measure: walking distance.
Statistical Analysis:
All statistical analyses will be performed with IBM SPSS Statistics (version 25) and datasets of all study participants will be analyzed on an intention-to-treat basis. Summary statistics (frequency, mean, standard deviation,) will be generated for all of the main demographic variables; gender, age, BMI, severity of CP according to GMFCS level, and treatment type. t- tests will be performed to determine statistically significant differences between the groups at baseline, statistically significant differences from pre- to post-training for each training group, and statistically significant differences between the training conditions on the outcomes: balance parameters, gross motor functions and Walking distance. Results will be presented as means ± standard deviation (SD) and the differences will be considered significant by keeping the Ninety-five percent confidence interval with a two-tailed level of significance set at p < 0.05 (Sarhan et al., 2014).
Study design
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Single blind (outcomes assessor)
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| Robotic assisted gait training: participants in this group with receive gait training on the Lokomat | Active comparator | Device: Participants this group will receive gait training in robotic assisted gait training (RAGT) three times per week for eight weeks |
| Body Weight Supported Treadmill Training: participants in this group receive training on Treadmill | Active comparator | Device: Body Weight Supported Treadmill Training |
Who may qualify
- Ages
- 5 to 14 years
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Child
Key inclusion criteria (8 listed)
- Spastic CP diagnosed from a pediatrician's (Neurology clinic) to have Diaplegia, Diaparesis, Hemiplegia, Hemiparesis, or Quadriparesis.
- Both gender with their age ranged from 5-14 years.
- Independently able to stand and walk or walk with assistance.
- GMFCS Level I and II, with walking limitations, but able to ambulate without the gait device for most distances and with GMFCS Level III, who have a greater degree of walking limitation and able to use wheelchairs or walkers for short to long distances.
- Ability to follow instructions.
Key exclusion criteria (13 listed)
- Botox injection in lower limb during the last 6 months.
- Surgical intervention in lower limb within a 1-year period prior to the examination date (including tendon release, muscle lengthening and bone surgery).
- Active drug for resisting epilepsy.
- Anatomical leg length differences larger than 2 cm (due to the limitations of Lokomat system).
- Bone-articular instability (joint dislocation).
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Participants this group will receive gait training in robotic assisted gait training (RAGT) three times per week for eight weeksRobotic Assited Gait Training is a device used to train children with CP how to walk in effective manner by connecting their body to the harness, robotic devices that attached to the electronic treadmill | Device | Robotic assisted gait training: participants in this group with receive gait training on the Lokomat |
| Body Weight Supported Treadmill TrainingParticipants in this group will receive gait training on conventional treadmill three times per week for eight weeks | Device | Body Weight Supported Treadmill Training: participants in this group receive training on Treadmill |
Primary outcome
Postural Stability using Computerized Dynamic Posturography (CDP)
Time frame: Outcome measure performed at baseline (within 1-2 weeks before starting the intervention) and after ending the intervention (within 1-2 weeks after completing the intervention)
1 secondary outcome
Change in gross motor functions measured by GMFM-88
Time frame: Outcome measure performed at baseline (within 1-2 weeks before starting the intervention) and after ending the intervention (within 1-2 weeks after completing the intervention)
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 5 Dec 2024.
- Derived from this study: PubMed 41045011Aljosh M, Algabbani MF, Fagehi JM, Bawazeer M, Almohiza MA, Albishi AM, Alhusaini AA. Robotic versus treadmill training: Postural stability in ambulatory CP: RCT study. Pediatr Int. 2025 Jan-Dec;67(1):e70214. doi: 10.1111/ped.70214.
- Individual participant dataSharing planned: Undecided
Related trials for CP (Cerebral Palsy)
Recruiting
Additional Effects on tDCS With AOT on Lower Limb Functions on Children With Diplegic CP
Diplegic Cerebral Palsy
Recruiting
Comparison of Vestibular Stimulation and Core Stability Training on Sitting Balance in Hypotonic CP
Hypotonic Cerebral Palsy
Not yet recruiting
Video-based Visual Feedback Combined With Task-oriented Physiotherapy Among Cerebral Palsy
Cerebral Palsy (CP)
RecruitingObservational study
Turkish Translation, Cross-Cultural Adaptation, Validity, and Reliability of the ABILHAND-Kids Young CP Scale
Cerebral Palsy
Active, not recruiting
Local Vibration for Drooling in Children With Cerebral Palsy
Cerebral Palsy (CP)
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
The record lists no contact. Use the official record to reach the sponsor.
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Participants this group will receive gait training in robotic assisted gait training (RAGT) three times per week for eight weeks and Body Weight Supported Treadmill Training in people with CP (Cerebral Palsy) and Robotic Exoskeleton, run by King Saud University at 1 site in Saudi Arabia.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 8 inclusion and 13 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 5 Dec 2024. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Saudi Arabia. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Postural Stability using Computerized Dynamic Posturography (CDP) (time frame: Outcome measure performed at baseline (within 1-2 weeks before starting the intervention) and after ending the intervention (within 1-2 weeks after completing the intervention)). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
On the ClinicalTrials.gov record for NCT06719271, which also lists 1 linked publication.
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 5 Dec 2024.